2346
J.A. Clement, A.K. Mohanakrishnan / Tetrahedron 66 (2010) 2340–2350
136.8, 133.6, 132.8, 132.3, 131.2, 131.1, 129.1, 128.3, 128.0, 127.9, 127.7,
143.4, 136.4, 133.3, 129.9, 129.4, 129.1, 128.3, 127.1, 126.9, 123.5,
127.2, 127.1, 124.9, 119.4, 106.0, 55.4; MS (EI): m/z (%)¼356 [M]þ.
122.0, 120.2, 111.1, 110.1, 83.1, 55.9; MS (EI): m/z (%)¼320 [M]þ.
4.3.8. 3-(4-(Diphenylamino)benzoyl)-2-naphthoic acid (12h). Con-
densation of keto-ester 11h (3.0 g, 8.04 mmol) and phthalaldehyde
7 (1.07 g, 8.04 mmol) using the procedure similar to that of 8a
afforded compound 12h (2.05 g, 60%) as a colorless solid; mp
120 ꢀC; [Found: C, 81.1; H, 4.8; N, 3.0. C30H21NO3 requires C, 81.25;
H, 4.77; N, 3.16%]; Rf (30% EA/hexane) 0.55; nmax (KBr) 3559, 1635,
4.3.13. 3-(3,5-Dimethoxyphenyl)naphtho[2,3-c]furan-1(3H)-one
(13c). Reductive cyclization of acid 12c (3.5 g, 10.41 mmol) using
NaBH4 (1.54 g, 41.66 mmol) adopting the same procedure as that of
9a afforded compound 13c (2.36 g, 71%) as a colorless solid; mp
160 ꢀC; [Found: C, 74.8; H, 5.1. C20H16O4 requires C, 74.99; H, 5.03%];
Rf (10% EA/hexane) 0.69; nmax (KBr) 2840, 1756, 1545 cmꢁ1
; dH
1695, 1571 cmꢁ1
;
dH (300 MHz, CDCl3) 8.68 (1H, s, ArH), 7.94 (1H, d,
(300 MHz, CDCl3) 8.50 (1H, s, ArH), 8.04 (1H, d, J 7.5 Hz, ArH), 7.86
(1H, d, J 7.8 Hz, ArH), 7.78 (1H, s, ArH), 7.61–7.56 (2H, m, ArH), 7.01
(1H, d, J 8.4 Hz, ArH), 6.89 (1H, s, ArH), 6.52 (1H, s, ArH), 6.41 (1H, d,
J 8.4 Hz, ArH), 3.83 (3H, s, OCH3), 3.79 (3H, s, OCH3); dC (75.6 MHz,
CDCl3) 170.9, 161.7, 158.7, 144.1, 136.4, 133.1, 129.9, 128.8, 128.7,
128.3, 126.8, 126.6, 124.2, 121.6, 117.9, 104.5, 98.9, 78.6, 55.6, 55.4;
MS (EI): m/z (%)¼320 [M]þ.
J 7.2 Hz, ArH), 7.90–7.87 (2H, m, ArH), 7.68–7.60 (3H, m, ArH), 7.34–
7.28 (5H, m, ArH), 7.20–7.11 (7H, m, ArH), 6.96 (2H, d, J 8.4 Hz, ArH);
dC (75.6 MHz, CDCl3) 195.3, 170.8, 152.3, 146.4, 138.2, 134.4, 132.9,
132.4, 131.5, 129.6, 129.4, 129.3, 128.2, 128.0, 127.8, 126.2, 126.1,
124.8, 119.2; MS (EI): m/z (%)¼443 [M]þ.
4.3.9. 3-(Benzo[b]thenoyl)-2-naphthoic acid (12i). Condensation of
keto-ester 11i (3.0 g, 11.45 mmol) and phthalaldehyde 7 (1.53 g,
11.45 mmol) using the procedure similar to that of 8a afforded
compound 12i (2.54 g, 69%) as a colorless solid; mp 210 ꢀC; [Found:
C, 72.3; H, 3.7; S, 9.8. C20H12O3S requires C, 72.12; H, 3.64; S, 9.65%];
4.3.14. 3-(3,4,5-Trimethoxyphenyl)naphtho[2,3-c]furan-1(3H)-one
(13d). Reductive cyclization of acid 12d (3.5 g, 9.56 mmol) using
NaBH4 (1.41 g, 38.25 mmol) adopting the same procedure as that of
9a afforded compound 13d (2.54 g, 76%) as a colorless solid; mp
134 ꢀC; [Found: C, 71.7; H, 5.3. C21H18O5 requires C, 71.99; H, 5.18%];
Rf (30% EA/hexane) 0.55; nmax (KBr) 3547, 1641, 1692, 1561 cmꢁ1
; dH
(300 MHz, DMSO-d6) 8.61–8.57 (2H, m, ArH), 8.13 (1H, s, ArH),
8.03–7.98 (4H, m, ArH), 7.69–7.66 (2H, m, ArH), 7.55–7.46 (2H, m,
ArH); dC (75.6 MHz, DMSO-d6) 191.1, 167.4, 140.8, 139.7, 137.9, 136.3,
135.3,133.4,132.3, 131.1,129.1,128.9, 128.3, 128.2, 127.8, 127.6, 125.7,
125.6, 124.6, 122.8; MS (EI): m/z (%)¼332 [M]þ.
Rf (10% EA/hexane) 0.55; nmax (KBr) 2840, 1756, 1545 cmꢁ1
; dH
(300 MHz, CDCl3) 8.51 (1H, s, ArH), 8.06–8.03 (1H, m, ArH), 7.87–
7.85 (1H, m, ArH), 7.77–7.74 (1H, m, ArH), 7.63–7.57 (2H, m, ArH),
6.83–6.73 (2H, m, ArH), 6.62–6.59 (1H, m, ArH), 3.87–3.77 (9H, m,
OCH3); dC (75.6 MHz, CDCl3) 170.7, 159.4, 152.5, 143.9, 142.4, 136.3,
133.1, 129.9, 128.8, 128.3, 126.9, 126.6, 124.2, 123.0, 121.6, 107.1, 79.4,
61.3, 60.8, 56.0; MS (EI): m/z (%)¼350 [M]þ.
4.3.10. 3-(Carbazoyl)-2-naphthoic acid (12j). Condensation of keto-
ester 11j (3.0 g, 7.37 mmol) and phthalaldehyde
7 (0.99 g,
7.37 mmol) using the procedure similar to that of 8a afforded
compound 12j (2.17 g, 62%) as a thick liquid; [Found: C, 80.3; H, 6.4;
N, 2.8. C32H31NO3 requires C, 80.47; H, 6.54; N, 2.93%]; Rf (30% EA/
4.3.15. 3-(Benzo[d][1,3]dioxol-5-yl)naphtho[2,3-c]furan-1(3H)-one
(13e). Reductive cyclization of acid 12e (2.0 g, 6.25 mmol) using
NaBH4 (0.93 g, 25.0 mmol) adopting the same procedure as that of
9a afforded compound 13e (1.40 g, 74%) as a colorless solid; mp
188 ꢀC; [Found: C, 75.2; H, 4.1. C19H12O4 requires C, 74.99; H, 3.97%];
hexane) 0.45; nmax (KBr) 3549, 2910, 1640, 1689, 1581 cmꢁ1
; dH
(300 MHz, CDCl3) 8.57 (2H, d, J 11.1 Hz, ArH), 7.99–7.83 (5H, m,
ArH), 7.56–7.55 (2H, m, ArH), 7.43 (1H, d, J 6.6 Hz, ArH), 7.36–7.29
(2H, m, ArH), 7.21–7.19 (1H, m, ArH), 4.08–4.06 (2H, m, N–CH2),
2.02–2.0 (1H, m, CH), 1.28–1.23 (8H, m, CH2), 0.85–0.83 (6H, m,
CH3); dC (75.6 MHz, CDCl3) 196.7 170.7, 143.8, 141.6, 138.6, 134.4,
132.9, 132.5, 129.3, 128.7, 128.2, 128.1, 128.0, 127.7, 126.4, 123.5,
123.2, 122.6, 120.7, 119.9, 109.5, 108.6, 60.5, 47.6, 39.4, 30.9, 28.7,
24.3, 14.0, 10.9; MS (EI): m/z (%)¼477 [M]þ
Rf (10% EA/hexane) 0.61; nmax (KBr) 2840, 1756, 1545 cmꢁ1
; dH
(300 MHz, CDCl3) 8.51 (1H, s, ArH), 8.05 (1H, d, J 6.3 Hz, ArH), 7.87
(1H, d, J 6.9 Hz, ArH), 7.72 (1H, s, ArH), 7.61–7.59 (2H, m, ArH), 6.87–
6.79 (2H, m, ArH), 6.64–6.63 (1H, m, ArH), 6.47–6.46 (1H, s, ArH),
5.93 (2H, s, OCH2); dC (75.6 MHz, CDCl3) 170.3, 148.6, 148.3, 143.4,
136.4, 133.3, 130.0, 129.9, 129.1, 128.3, 127.2, 126.9, 123.6, 122.0,
121.6, 108.4, 107.4, 101.5, 82.8; MS (EI): m/z (%)¼304 [M]þ.
4.3.11. 3-(4-Methoxyphenyl)naphtho[2,3-c]furan-1(3H)-one
(13a). Reductive cyclization of acid 12a (3.5 g, 11.43 mmol) using
NaBH4 (1.69 g, 45.75 mmol) adopting the procedure similar to that
of 9a afforded compound 13a (2.62 g, 79%) as a colorless solid; mp
202 ꢀC; [Found: C, 78.4; H, 4.8. C19H14O3 requires C, 78.61; H,
4.3.16. 3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)naphtho[2,3-c]furan-
1(3H)-one (13f). Reductive cyclization of acid 12f (2.0 g, 5.98 mmol)
using NaBH4 (0.88 g, 23.95 mmol) adopting the same procedure as
that of 9a afforded compound 13f (1.45 g, 76%) as a colorless solid;
mp 215 ꢀC; [Found: C, 75.2; H, 4.3. C20H14O4 requires C, 75.46; H,
4.86%]; Rf (10% EA/hexane) 0.61; nmax (KBr) 2840, 1759, 1565 cmꢁ1
;
4.43%]; Rf (10% EA/hexane) 0.58; nmax (KBr) 2860, 1759, 1565 cmꢁ1
;
dH (300 MHz, CDCl3) 8.53 (1H, s, ArH), 8.07 (1H, d, J 8.1 Hz, ArH),
7.87 (1H, d, J 7.5 Hz, ArH), 7.73 (1H, s, ArH), 7.63–7.59 (2H, m, ArH),
7.24 (2H, d, J 8.7 Hz, ArH), 6.90 (2H, d, J 8.4 Hz, ArH), 6.54 (1H, s,
ArH), 3.81 (3H, s, OCH3); dC (75.6 MHz, CDCl3) 170.6, 160.4, 143.6,
136.4, 133.3, 129.9, 129.1, 129.0, 128.9, 128.3, 127.1, 126.9, 123.8,
122.0, 114.3, 82.8, 55.4; MS (EI): m/z (%)¼290 [M]þ.
dH (300 MHz, DMSO-d6) 8.56 (1H, s, ArH), 8.17 (1H, d, J 7.5 Hz, ArH),
7.99 (1H, d, J 7.8 Hz, ArH), 7.87 (1H, s, ArH), 7.69–7.62 (2H, m, ArH),
6.87–6.79 (3H, m, ArH), 6.64 (1H, s, ArH), 4.23–4.21 (4H, m, OCH2);
dC (75.6 MHz, DMSO-d6) 169.5,143.9,143.4,143.3,135.9,132.7,130.1,
129.6, 128.7, 128.1, 126.8, 126.2, 122.9, 121.8, 119.9, 117.3, 115.9, 81.8,
63.9, 63.8; MS (EI): m/z (%)¼318 [M]þ.
4.3.12. 3-(3,4-Dimethoxyphenyl)naphtho[2,3-c]furan-1(3H)-one
(13b). Reductive cyclization of acid 12b (3.5 g, 10.41 mmol) using
NaBH4 (1.54 g, 41.66 mmol) adopting the same procedure as that of
9a afforded compound 13b (2.49 g, 75%) as a colorless solid; mp
158 ꢀC; [Found: C, 74.8; H, 4.9. C20H16O4 requires C, 74.99; H,
4.3.17. 3-(2-Methoxynaphthalen-6-yl)naphtho[2,3-c]furan-1(3H)-
one (13g). Reductive cyclization of acid 12g (2.0 g, 5.61 mmol)
using NaBH4 (0.83 g, 22.47 mmol) adopting the same procedure
as that of 9a afforded compound 13g (1.43 g, 75%) as a colorless
solid; mp 180 ꢀC; [Found: C, 81.0; H, 4.8. C23H16O3 requires C,
81.16; H, 4.74%]; Rf (10% EA/hexane) 0.61; nmax (KBr) 2852, 1759,
5.03%]; Rf (10% EA/hexane) 0.69; nmax (KBr) 2845, 1758, 1548 cmꢁ1
;
dH (300 MHz, CDCl3) 8.35 (1H, s, ArH), 8.08–8.05 (1H, m, ArH), 7.89–
7.87 (1H, m, ArH), 7.75 (1H, s, ArH), 7.64–7.62 (2H, m, ArH), 6.95–
6.87 (2H, m, ArH), 6.74 (1H, s, ArH), 6.53 (1H, s, ArH), 3.87 (3H, s,
OCH3), 3.79 (3H, s, OCH3); dC (75.6 MHz, CDCl3) 170.6, 149.9, 149.4,
1549 cmꢁ1
; dH (300 MHz, CDCl3) 8.59 (1H, s, ArH), 8.09 (1H, d, J
8.7 Hz, ArH), 7.87–7.82 (2H, m, ArH), 7.77–7.70 (3H, m, ArH),
7.65–7.59 (2H, m, ArH), 7.27–7.12 (3H, m, ArH), 6.71 (1H, s, ArH),
3.93 (3H, s, OCH3); dC (75.6 MHz, CDCl3) 170.5, 158.4, 143.6, 136.4,